Related Articles
First‑line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study
Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low‑intermediate risk
Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first‑line treatment for Japanese patients with metastatic colorectal cancer
Prognostic value of parameters derived from white blood cell and differential counts in patients receiving palliative radiotherapy
Influence of initiation time and white blood cell count on the efficacy of cytotoxic agents in acute promyelocytic leukemia during induction treatment